Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Prota Therapeutics Pty Ltd. maintains a company patent portfolio focused on the Biotechnology & Pharmaceuticals technology area. The portfolio currently shows 1 pending office action. This 1 action is being processed by a distinct examiner within a distinct art unit, which indicates a highly focused prosecution environment.
ROONEY, NORA MAUREEN is identified as the busiest examiner for this portfolio, with 1 pending office action under review. This examiner is responsible for the total active workload of the portfolio. For a practitioner, this means that all current patent office interactions are consolidated under a sole individual within the Biotechnology & Pharmaceuticals sector.
The use of a distinct art unit suggests that the pending matters involve a specific technical niche. Practitioners should focus their strategy on the specific examination patterns of ROONEY, NORA MAUREEN. Since the busiest examiner pending count matches the total number of pending office actions, the practitioner can ensure a consistent and unified approach to the pending intellectual property.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| No statute on record | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ROONEY, NORA MAUREEN | 1 | 60.4% | +23.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17787864 | ALLERGY TREATMENT | ROONEY, NORA MAUREEN | — |
| Art Unit | Apps |
|---|---|
| 1641 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17787864 | ALLERGY TREATMENT | ROONEY, NORA MAUREEN | 1641 | Other | Non-Final OA | — | Pending | Jun 21, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialProta Therapeutics Pty Ltd. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Nora Maureen Rooney has the most, with 1 of Prota Therapeutics Pty Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.